Refractory arterial hypertension: clinical manifestations and controversies

dc.contributor.author	Karpenko, Yu. I.	en
dc.contributor.author	Garmazi, S.	en
dc.date.accessioned	2020-02-13T11:05:30Z
dc.date.available	2020-02-13T11:05:30Z
dc.date.issued	2015
dc.identifier.citation	Karpenko Yu. I., Garmazi S. Refractory arterial hypertension: clinical manifestations and controversies // Journal of Education, Health and Sport. 2015. Vol. 5, N 11. P. 238-244.	en
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/6462
dc.description.abstract	The study was aimed to assess the clinical manifestations in patients with refractory hypertension. There was demonstrated that refractory arterial hypertension is characterized with hyperactivation of sympathetic nervous system. Patients with RAH used 4,6 ± 0,2 medications to control the pressure. The most common combinations are the combination of blockers, ACE inhibitors and diuretics, ACE inhibitors and diuretics, and, ACC, more rarely, patients received a combination of ARB and a diuretic ACC. Every third patient in therapy included 4 or more antihypertensive drugs, that is, there was a polypharmacy. However the combination of used medications and their dosage regimen does not achieve significant clinical effect.	en
dc.language.iso	en	en
dc.subject	arterial hypertension	en
dc.subject	medication resistance	en
dc.subject	diagnostics	en
dc.subject	monitoring	en
dc.title	Refractory arterial hypertension: clinical manifestations and controversies	en
dc.type	Article	en